ANGLO_MEDICAL_LIMITED - Accounts


Company Registration No. 06796063 (England and Wales)
ANGLO MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020
PAGES FOR FILING WITH REGISTRAR
ANGLO MEDICAL LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
ANGLO MEDICAL LIMITED
BALANCE SHEET
AS AT
30 JUNE 2020
30 June 2020
- 1 -
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
3
10,406
12,242
Current assets
Debtors
4
219,472
206,765
Cash at bank and in hand
441,521
298,745
660,993
505,510
Creditors: amounts falling due within one year
5
(642,783)
(427,815)
Net current assets
18,210
77,695
Total assets less current liabilities
28,616
89,937
Creditors: amounts falling due after more than one year
6
(1,793)
-
Net assets
26,823
89,937
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
26,723
89,837
Total equity
26,823
89,937

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 June 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

ANGLO MEDICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 JUNE 2020
30 June 2020
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 20 March 2021
Mrs E Kitromilides
Director
Company Registration No. 06796063
ANGLO MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2020
- 3 -
1
Accounting policies
Company information

Anglo Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is 7d Dragoon House, Hussar Court, Waterlooville, Hampshire, United Kingdom, PO7 7SF.

1.1
Accounting convention

The financial statements are prepared under the historical cost convention and in accordance with the FRS 102 Section 1A Small Entities - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

1.2
Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Tangible fixed assets

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures and fittings
15 % RB
Computers
15 % RB
Motor vehicles
15 % RB

 

 

ANGLO MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2020
1
Accounting policies
(Continued)
- 4 -
1.4
Financial instruments

Debt instruments (other than those wholly repayable or receivable within one year, and loans from directors who are also shareholders), including loans and other accounts receivable and payable, are initially measured at the present value of the future cash flows and subsequently at amortised cost using the effective interest method.

 

Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, and loans from directors who are also shareholders, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received.

 

Financial assets are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.

 

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to offset the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

ANGLO MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2020
1
Accounting policies
(Continued)
- 5 -
1.5
Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

 

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

 

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

 

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

 

Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

 

 

Current tax

The tax expense represents the sum of the tax currently payable and deferred tax.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

ANGLO MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2020
1
Accounting policies
(Continued)
- 6 -
1.6
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

Government grants relating to turnover are recognised as income over the periods when the related costs are incurred. Grants relating to an asset are recognised in income systematically over the asset's expected useful life. If part of such a grant is deferred it is recognised as deferred income rather than being deducted from the asset's carrying amount.

 

The grants claimed within this financial period are in respect of Covid-19 and relate to staff furlough claims and a council tax rebate.

1.7

Pensions

The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2020
2019
Number
Number
Total
3
3
3
Tangible fixed assets
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
Cost
At 1 July 2019 and 30 June 2020
713
14,083
25,884
40,680
Depreciation and impairment
At 1 July 2019
487
6,781
21,170
28,438
Depreciation charged in the year
34
1,095
707
1,836
At 30 June 2020
521
7,876
21,877
30,274
Carrying amount
At 30 June 2020
192
6,207
4,007
10,406
At 30 June 2019
226
7,302
4,714
12,242
ANGLO MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2020
- 7 -
4
Debtors
2020
2019
Amounts falling due within one year:
£
£
Trade debtors
217,486
195,850
Other debtors
1,986
10,915
219,472
206,765
5
Creditors: amounts falling due within one year
2020
2019
£
£
Trade creditors
612,760
390,743
Taxation and social security
26,408
18,941
Other creditors
3,615
18,131
642,783
427,815
6
Creditors: amounts falling due after more than one year
2020
2019
£
£
Other creditors
1,793
-
2020-06-302019-07-01false20 March 2021CCH SoftwareCCH Accounts Production 2020.310Medical Intermediary
Mrs E Kitromilides
067960632019-07-012020-06-30067960632020-06-30067960632019-06-3006796063core:FurnitureFittings2020-06-3006796063core:ComputerEquipment2020-06-3006796063core:MotorVehicles2020-06-3006796063core:FurnitureFittings2019-06-3006796063core:ComputerEquipment2019-06-3006796063core:MotorVehicles2019-06-3006796063core:CurrentFinancialInstrumentscore:WithinOneYear2020-06-3006796063core:CurrentFinancialInstrumentscore:WithinOneYear2019-06-3006796063core:CurrentFinancialInstruments2020-06-3006796063core:CurrentFinancialInstruments2019-06-3006796063core:Non-currentFinancialInstruments2020-06-3006796063core:ShareCapital2020-06-3006796063core:ShareCapital2019-06-3006796063core:RetainedEarningsAccumulatedLosses2020-06-3006796063core:RetainedEarningsAccumulatedLosses2019-06-3006796063bus:Director12019-07-012020-06-3006796063core:FurnitureFittings2019-07-012020-06-3006796063core:ComputerEquipment2019-07-012020-06-30067960632018-07-012019-06-3006796063core:FurnitureFittings2019-06-3006796063core:ComputerEquipment2019-06-3006796063core:MotorVehicles2019-06-30067960632019-06-3006796063core:MotorVehicles2019-07-012020-06-3006796063core:WithinOneYear2020-06-3006796063core:WithinOneYear2019-06-3006796063bus:PrivateLimitedCompanyLtd2019-07-012020-06-3006796063bus:SmallCompaniesRegimeForAccounts2019-07-012020-06-3006796063bus:FRS1022019-07-012020-06-3006796063bus:AuditExemptWithAccountantsReport2019-07-012020-06-3006796063bus:FullAccounts2019-07-012020-06-30xbrli:purexbrli:sharesiso4217:GBP